Shareholder Alert: Robbins LLP Announces that Odonate Therapeutics, Inc. (ODT) is Being Sued for Misleading Shareholders
SAN DIEGO–(BUSINESS WIRE)–Shareholder rights law firm Robbins LLP announces that a purchaser of securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) has filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between December 7, 2017 and August 21, 2020. Based in San Diego, California, Odonate is a pharmaceutical company that develops therapeutics for the treatment of cancer. The Company is developing tesetaxel, an oral chemotherapy.
If you suffered a loss due to Odonate Therapeutics, Inc.’s misconduct, click here.
Odonate Therapeutics, Inc. (ODT) Accused of Misrepresenting Potential of New Cancer Drug
According to the complaint, during the relevant period, Odonate…
